Estrogen therapy in patients with prostate cancer: a contemporary systematic review

ConclusionsDES might be similarly effective to other forms of ADT on advanced PCa patients, with potential important roles. Intriguingly, the burden of severe cardiovascular toxicity is mainly related to old-fashioned doses of 5.0 and 3.0  mg. Modern PCa hormonal knowledge warrants stout high-quality prospective randomized trials in the low-dose 1 mg DES scenario.
Source: International Urology and Nephrology - Category: Urology & Nephrology Source Type: research